Results 101 to 110 of about 1,348,714 (289)
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
Expression of neuropeptides – galanin and Reg2 - in subcategories of nociceptors after nerve injury [PDF]
PhDNeuropeptides show dynamic changes in expression after nerve injury, and have been implicated in chronic pain states. I sought to compare expression of two peptides which are upregulated after nerve injury, galanin and Reg2, and to determine the ...
Burrows, Karen Lynne
core +3 more sources
Image segmentation plays a crucial role in medical analysis, particularly in accurately identifying anatomical structures. In dental implant planning, the identification of the Inferior Alveolar Nerve (IAN) is critical to avoid complications resulting ...
Arsy Bilahi Tama, Nanik Suciati
doaj +1 more source
Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study. [PDF]
Background: Vagus nerve stimulation has been successfully used as a treatment strategy for epilepsy and affective disorders for years. Transcutaneous vagus nerve stimulation (tVNS) is a new non-invasive method to stimulate the vagus nerve, which has been
Berthold Langguth +28 more
core +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
A Place Based Approach to Net Zero. A report by the Net Zero Infrastructure Industry Coalition
This report was produced as part of the work programme of the Net-Zero Infrastructure Industry Coalition, formed in 2019 in response to the UK government’s 2050 net- zero greenhouse gas (GHG) emissions commitment.
Knowland, T +4 more
core +1 more source
A net for extending the optic nerve at enucleation of the eyeball. [PDF]
A long section of optic nerve can be obtained during enucleation, when the eyeball is caught in a net made specifically for this purpose. The net is knitted from surgical thread and is in the shape of a barrel with two openings: one wide, one narrow. Separate thread is wrapped around the edge of the wide opening.
openaire +2 more sources
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran +13 more
wiley +1 more source

